Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor
Clinical trial NCT02151357 · TERMINATED
Trial details
- NCT number
- NCT02151357
- Sponsor
- Standard Chem. & Pharm. Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-19
- Primary completion
- 2016-06-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.